Leadership Overview
Granules has 8 executives leading key functions including operations, technology, human resources, finance, strategy, portfolio management, and formulation.
Driven by a commitment to excellence, Granules is dedicated to manufacturing high-quality pharmaceutical products with a steadfast focus on customer centricity, impacting global health outcomes.
Driven by a commitment to excellence, Granules is dedicated to manufacturing high-quality pharmaceutical products with a steadfast focus on customer centricity, impacting global health outcomes.
Leadership Roles at Granules
Mukesh Surana - Global Chief Financial Officer
Mukesh Surana, the Global Chief Financial Officer at Granules, directs the company's financial strategy and fiscal operations worldwide. This executive is responsible for financial planning, budgeting, risk management, and ensuring the financial health and sustainability of Granules' integrated pharmaceutical manufacturing business. The Global Chief Financial Officer oversees all accounting functions, investor relations, and capital allocation, driving financial performance in alignment with strategic objectives. Mukesh Surana's leadership ensures robust financial controls and compliance with international accounting standards, supporting the company's high-growth trajectory. By managing financial resources effectively, this role directly enables Granules to invest in research, development, and expansion of its API, FD, and Speciality Products. The financial acumen provided by the Global Chief Financial Officer is paramount to achieving profitability and enhancing shareholder value in the competitive global market.
Jai Velusamy - Chief Operating Officer
Jai Velusamy, the Chief Operating Officer at Granules, directs all operational facets of the company's integrated pharmaceutical manufacturing. Overseeing production across multiple facilities, Jai Velusamy ensures the efficient and high-quality output of Active Pharmaceutical Ingredients (API), Finished Dosage Forms (FD), and Speciality Products. This leadership role involves optimizing manufacturing processes, managing supply chain logistics, and driving operational excellence to meet stringent global regulatory standards. By focusing on process improvement and resource allocation, the Chief Operating Officer directly supports Granules' mission of delivering superior pharmaceutical products. The operational strategy under Jai Velusamy's guidance is critical for scaling production capacity and maintaining cost-effectiveness in a competitive market. This executive's oversight guarantees the seamless execution of manufacturing plans, aligning production with market demand and company growth objectives.
Vijay Raghavan - Global President, Portfolio
Vijay Raghavan, the Global President, Portfolio at Granules, leads the strategic development and management of the company's diverse product portfolio. This executive is responsible for identifying market opportunities, driving innovation in product development, and ensuring that Granules' offerings meet evolving global healthcare needs. The Global President, Portfolio oversees the lifecycle management of all products, from conceptualization through market launch and beyond, ensuring alignment with the company's customer-centric mission. Vijay Raghavan's strategic vision guides the expansion of Granules' presence in key therapeutic areas, focusing on high-quality API, FD, and Speciality Products. By optimizing the product pipeline and fostering strategic partnerships, this role directly contributes to the company's sustained growth and market leadership. The comprehensive portfolio strategy executed by the Global President, Portfolio is critical for Granules' long-term success and impact.
Ramraj Rangarajalu - President, Formulation Operations (India)
Ramraj Rangarajalu, the President, Formulation Operations (India) at Granules, directs the comprehensive manufacturing and operational activities for Finished Dosage (FD) products within India. This executive ensures the efficient production of high-quality formulations, adhering to stringent regulatory standards and the company's customer-centric philosophy. The President, Formulation Operations (India) oversees all aspects of formulation manufacturing, including process optimization, quality control, and supply chain management for the Indian market. Ramraj Rangarajalu's leadership is pivotal in scaling production capacity and enhancing operational efficiency to meet domestic and international demand for Granules' pharmaceutical products. By driving excellence in formulation operations, this role directly supports the company's mission to deliver accessible and superior healthcare solutions. The strategic oversight provided by the President, Formulation Operations (India) is fundamental to Granules' manufacturing prowess and market competitiveness.
Srinivas Pv - Chief Technology Officer
Srinivas Pv, the Chief Technology Officer at Granules, architects the company's technological infrastructure and innovation roadmap. This executive spearheads the integration of advanced technologies across all manufacturing and operational domains, ensuring Granules remains at the forefront of pharmaceutical production. The Chief Technology Officer's responsibilities include overseeing digital transformation initiatives, enhancing data security, and implementing cutting-edge solutions that improve efficiency and product quality. Srinivas Pv drives the adoption of new scientific methodologies and digital tools, directly supporting the company's focus on customer centricity and product development. By fostering a culture of technological advancement, this role ensures that Granules leverages the latest innovations to maintain its competitive edge in the global pharmaceutical market. The strategic direction provided by the Chief Technology Officer is vital for future-proofing operations and expanding the company's technological capabilities.
Vinod Parur - Chief Human Resources Officer
Vinod Parur, the Chief Human Resources Officer at Granules, shapes the organization's talent strategy and cultivates a high-performance work environment. This executive leads all human capital initiatives, focusing on attracting, developing, and retaining top talent essential for Granules' growth in the pharmaceutical sector. The Chief Human Resources Officer oversees employee relations, compensation and benefits, organizational development, and the implementation of HR policies that align with the company's customer-centric mission. Vinod Parur plays a crucial part in fostering a culture of collaboration and innovation, ensuring that the workforce is equipped with the skills and motivation to drive business success. By championing employee well-being and professional growth, this role directly contributes to operational efficiency and sustained market impact. The strategic HR planning executed by the Chief Human Resources Officer is fundamental to Granules' ability to scale and adapt to evolving industry demands.
Vijay Kandpal - Chief of Staff to Chairman & Managing Director
Vijay Kandpal, the Chief of Staff to Chairman & Managing Director at Granules, provides strategic support and operational coordination across key initiatives. This executive acts as a central point of contact, facilitating communication and driving the execution of directives from the Chairman & Managing Director. The Chief of Staff to Chairman & Managing Director oversees special projects, manages cross-functional team alignment, and ensures that strategic priorities are translated into actionable plans. Vijay Kandpal's role is critical in enhancing organizational efficiency and ensuring that the company's customer-centric approach is embedded in all operational activities. By streamlining workflows and optimizing resource deployment, this executive directly contributes to the company's overall performance and market impact. The strategic insights and operational management provided by the Chief of Staff to Chairman & Managing Director are essential for navigating complex business challenges and achieving sustained growth.
Sriram Chavali - EA-Chief of Staff, Directorate
Sriram Chavali, the EA-Chief of Staff, Directorate at Granules, provides essential support to the Directorate, ensuring seamless operational flow and strategic execution. This executive manages critical administrative functions and coordinates key projects, facilitating efficient decision-making and communication across various departments. The EA-Chief of Staff, Directorate's responsibilities include overseeing project timelines, preparing essential documentation, and ensuring that the Directorate's objectives are met with precision and timeliness. Sriram Chavali plays a vital role in enhancing the productivity of the leadership team, directly supporting Granules' commitment to manufacturing high-quality pharmaceutical products. By optimizing internal processes and managing key operational interfaces, this role contributes significantly to the company's customer-centric focus and overall market performance. The diligent support provided by the EA-Chief of Staff, Directorate is fundamental to the sustained operational excellence of Granules.
Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership CS
HL
AJ
CO
Founded in 1945 and headquartered in Mandaluyong, Philippines Unilab is a manufacturer of pharmaceuticals and other similar products.
Company Leadership RG
SB
LV
JC
Alvogen, founded in 2009 headquartered in Morristown, New Jersey, operates as a pharmaceutical company. The Company develops, manufactures, and markets parallel imported and generic drugs. Alvogen Pharma US serves clients worldwide.
Company Leadership NB
JL
SP
JJ
ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. The Companys range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates natural killer cells, T cells, and memory T cells for a long-duration response. The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.
Company Leadership FJ
Frequently Asked Questions Regarding Granules Top Executives and Leadership Team
